MSR (Methionine Sulfoxide Reductase) inhibitors represent a class of compounds that interfere with the activity of methionine sulfoxide reductase enzymes. These enzymes play a crucial role in the reduction of methionine sulfoxide back to methionine, a reversible modification that occurs when methionine residues in proteins are oxidized under oxidative stress. Methionine sulfoxide reductases are highly conserved across various species, and their enzymatic activity is fundamental to maintaining protein function, redox balance, and mitigating oxidative damage. By inhibiting MSR enzymes, compounds classified as MSR inhibitors modulate the redox state of methionine residues in proteins, potentially leading to the accumulation of methionine sulfoxide and disruption of normal protein function. This inhibition can have a significant impact on various cellular processes, particularly those that are sensitive to changes in oxidative balance.
Structurally, MSR inhibitors vary, but they often target the enzyme's active site or interact with co-factors required for its catalytic function. Some inhibitors may function by mimicking the natural substrates of MSR enzymes, while others may interfere with the electron transfer processes necessary for methionine sulfoxide reduction. The development of these inhibitors requires a deep understanding of the enzyme's structure and mechanism, as well as the oxidative pathways in which methionine sulfoxide reductase operates. This class of inhibitors is particularly interesting for research focused on oxidative stress, protein oxidation, and redox biology, providing insights into how cells respond to and manage oxidative insults at the molecular level. By studying MSR inhibitors, researchers can further elucidate the roles of methionine sulfoxide reductase in protein repair, longevity, and oxidative damage control.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
As a dihydrofolate reductase inhibitor, Methotrexate reduces the availability of methyl donors, which could possibly inhibit MSR activity. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $60.00 $75.00 $125.00 $205.00 | 8 | |
Can inhibit folate absorption, reducing the MSR substrate 5-methyltetrahydrofolate, which could possibly inhibit MSR activity. | ||||||
Trimethoprim | 738-70-5 | sc-203302 sc-203302A sc-203302B sc-203302C sc-203302D | 5 g 25 g 250 g 1 kg 5 kg | $66.00 $158.00 $204.00 $707.00 $3334.00 | 4 | |
Inhibits dihydrofolate reductase, potentially limiting the regeneration of active folate forms for MSR action, which could possibly inhibit MSR. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Disrupts deoxyribonucleotide synthesis, which could possibly inhibit the folate cycle and subsequently MSR function. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
As a dihydrofolate reductase antagonist, Aminopterin could possibly inhibit the folate pool and MSR's function. | ||||||
Pyrimethamine | 58-14-0 | sc-208190 sc-208190A sc-208190B | 1 g 5 g 25 g | $78.00 $233.00 $809.00 | 5 | |
Inhibits dihydrofolate reductase and could decrease folate availability for MSR pathways, which could possibly inhibit MSR. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $199.00 $173.00 $342.00 $495.00 $690.00 | 1 | |
Impacts purine synthesis; by extension, it might affect the folate cycle and could possibly inhibit MSR activity. | ||||||